QuantHealth Raises $45M Series B for AI Trial Platform
Get the Tech newsletter
Daily tech — startups, AI labs, chips, the launches that shape the next decade. Free.
- QuantHealth raised a $45M Series B led by Qumra Capital, bringing the Tel Aviv-based company's total funding to approximately $70M.
- QuantHealth provides AI-powered clinical trial simulation software, positioning it in the intersection of artificial intelligence and drug development tooling.
Why it matters: The $45M round, bringing QuantHealth's cumulative funding to ~$70M, shows continued investor conviction in AI-native tools aimed at the clinical trial process — a notoriously slow and expensive stage of drug development.
Ask SkimNews
